Randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke

Completed

Phase N/A Results

Trial Description

Interventions

  • Nimodipine (NimotopĀ®)Drug
    Intervention Desc: Calcium channel blocker (L-type calcium channels)

Trial Design

Randomized, placebo-controlled, double-blind clinical trial of 31 patients.

Patient Involvement

Patients were randomized to receive nimodipine (120 mg/day) or placebo for 28 days. Treatment was begun within 48 hours of ischemic stroke.

Outcomes

Type Measure Time Frame Safety Issue
Primary Mathew's scale score at 4 weeks.